| abstract |
The present invention provides a rapidly dispersible solid preparation containing levetiracetam. A high dose of levetiracetam ((S) -2- (2-oxopyrrolidin-1-yl) butanamide; (-)-() in a porous matrix that is dispersed in water within a period of less than about 10 seconds. S) -α-ethyl-2-oxo-1-pyrrolidineacetamide), disintegrants, binders, antioxidants, optional flavoring agents, optional sweeteners, and optional glidants A three-dimensional printed dosage form effective for the treatment of wrinkles, cognitive impairment, etc. [Selection figure] None |